See more : Korea Zinc Company, Ltd. (010130.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Syensqo SA/NV (SYENS.BR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Syensqo SA/NV, a leading company in the Chemicals industry within the Basic Materials sector.
- Concord Healthcare Grp Co Ltd (2453.HK) Income Statement Analysis – Financial Results
- Ramkhamhaeng Hospital Public Company Limited (RAM.BK) Income Statement Analysis – Financial Results
- I.K Co., Ltd. (2722.T) Income Statement Analysis – Financial Results
- OneSpan Inc. (OSPN) Income Statement Analysis – Financial Results
- Prosper Gold Corp. (PGXFF) Income Statement Analysis – Financial Results
Syensqo SA/NV (SYENS.BR)
Industry: Chemicals
Sector: Basic Materials
About Syensqo SA/NV
Syensqo SA/NV operates as a specialty chemicals company. It operates in two divisions: Materials and Consumer and Resources. The Materials division consists of polymers and composites businesses primarily serving automotive, aerospace and defense, and electronics markets. The Consumer and Resources division provides specialty solutions to consumer-focused end-markets, such as agro, personal care, food, etc. The company is based in Brussels, Belgium.
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 7.07B | 8.12B | 6.03B | 5.38B |
Cost of Revenue | 4.69B | 5.52B | 4.15B | 3.82B |
Gross Profit | 2.38B | 2.60B | 1.88B | 1.56B |
Gross Profit Ratio | 33.62% | 32.06% | 31.23% | 28.99% |
Research & Development | 339.00M | 312.00M | 286.00M | 253.00M |
General & Administrative | 521.00M | 622.00M | 506.00M | 480.00M |
Selling & Marketing | 296.00M | 222.00M | 199.00M | 219.00M |
SG&A | 817.00M | 844.00M | 705.00M | 699.00M |
Other Expenses | 1.22B | -149.00M | -59.00M | -26.00M |
Operating Expenses | 2.38B | 1.28B | 1.14B | 1.10B |
Cost & Expenses | 5.98B | 6.80B | 5.29B | 4.92B |
Interest Income | 81.00M | 51.00M | 8.00M | 13.00M |
Interest Expense | 218.00M | 133.00M | 114.00M | 192.00M |
Depreciation & Amortization | 619.00M | 621.00M | 583.00M | 642.00M |
EBITDA | 1.17B | 1.70B | 1.15B | -317.00M |
EBITDA Ratio | 16.60% | 22.65% | 21.68% | 44.21% |
Operating Income | 1.08B | 1.30B | 737.00M | 451.00M |
Operating Income Ratio | 15.34% | 16.05% | 12.22% | 8.38% |
Total Other Income/Expenses | -695.00M | -338.00M | -262.00M | -1.57B |
Income Before Tax | 389.00M | 966.00M | 474.00M | -1.12B |
Income Before Tax Ratio | 5.51% | 11.89% | 7.86% | -20.76% |
Income Tax Expense | 192.00M | 2.00M | 22.00M | 165.00M |
Net Income | 193.00M | 950.00M | 444.00M | -1.29B |
Net Income Ratio | 2.73% | 11.70% | 7.36% | -23.88% |
EPS | 1.82 | 8.97 | 4.19 | -12.14 |
EPS Diluted | 1.82 | 8.97 | 4.19 | -12.14 |
Weighted Avg Shares Out | 105.83M | 105.88M | 105.88M | 105.88M |
Weighted Avg Shares Out (Dil) | 106.32M | 105.88M | 105.88M | 105.88M |
Source: https://incomestatements.info
Category: Stock Reports